trending Market Intelligence /marketintelligence/en/news-insights/trending/eoWmSYFS0bQq1m1Xu1BmSQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Australian Pharmaceutical sells entire shareholding in Sigma

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Australian Pharmaceutical sells entire shareholding in Sigma

Australian Pharmaceutical Industries Ltd. sold 137,264,592 shares of Sigma Healthcare Ltd. — its entire shareholding in the company.

The share sale follows a rejected takeover offer by API to acquire Rowville, Australia-based Sigma in March. The offer consisted of 0.31 of an API share and 23 Australian cents in cash per Sigma share.

Sigma, which is focused on wholesale and distribution of pharmaceutical products, previously said the offer was not in the best interests of its shareholders.

Regarding the decision to off-load its entire Sigma shareholding, API said its board decided that the strategic and commercial "fundamentals" that made the merger a compelling proposition have "significantly diminished."

Camberwell, Australia-based API engages in the wholesale distribution of pharmaceutical, medical, health, beauty and lifestyle products to pharmacies primarily in Australia.